Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics. These three divisions are supported by our research organization, the Novartis Institutes for BioMedical Research (NIBR), and a centralized services group, Novartis Business Services, to facilitate collaboration across our divisions, and drive efficiency and productivity gains.
We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.
Our global portfolio of innovative patented medicines includes more than 50 key marketed products, many of which are among the leaders in their therapeutic areas.
Our Sandoz Division is a global leader in generic medicines and biosimilars, offering more than 1 000 different types of high-quality, affordable products across a broad range of therapeutic areas. It pioneers new ways to help people around the world access high-quality medicines.